Dynamic interactions of high Cdt1 and geminin levels regulate S phase in early Xenopus embryos

被引:19
|
作者
Kisielewska, Jolanta [1 ]
Blow, J. Julian [2 ]
机构
[1] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland
来源
DEVELOPMENT | 2012年 / 139卷 / 01期
关键词
Cdt1:Geminin; DNA replication; Xenopus embryos; ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; CELL-CYCLE; PREVENTS REREPLICATION; LICENSING FACTOR; DOWN-REGULATION; RE-REPLICATION; NUCLEAR IMPORT; CHECKPOINT; EXPRESSION;
D O I
10.1242/dev.068676
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cdt1 plays a key role in licensing DNA for replication. In the somatic cells of metazoans, both Cdt1 and its natural inhibitor geminin show reciprocal fluctuations in their protein levels owing to cell cycle-dependent proteolysis. Here, we show that the protein levels of Cdt1 and geminin are persistently high during the rapid cell cycles of the early Xenopus embryo. Immunoprecipitation of Cdt1 and geminin complexes, together with their cell cycle spatiotemporal dynamics, strongly supports the hypothesis that Cdt1 licensing activity is regulated by periodic interaction with geminin rather than its proteolysis. Overexpression of ectopic geminin slows down, but neither arrests early embryonic cell cycles nor affects endogenous geminin levels; apparent embryonic lethality is observed around 3-4 hours after mid-blastula transition. However, functional knockdown of geminin by Delta Cdt1_193-447, which lacks licensing activity and degradation sequences, causes cell cycle arrest and DNA damage in affected cells. This contributes to subsequent developmental defects in treated embryos. Our results clearly show that rapidly proliferating early Xenopus embryonic cells are able to regulate replication licensing in the persistent presence of high levels of licensing proteins by relying on changing interactions between Cdt1 and geminin during the cell cycle, but not their degradation.
引用
收藏
页码:63 / 74
页数:12
相关论文
共 41 条
  • [31] Interactions between Swi1-Swi3, Mrc1 and S phase kinase, Hsk1 may regulate cellular responses to stalled replication forks in fission yeast (vol 14, pg 669, 2009)
    Shimmoto, Michie
    Matsumoto, Seiji
    Odagiri, Yukari
    Noguchi, Eishi
    Russell, Paul
    Masai, Hisao
    GENES TO CELLS, 2010, 15 (03) : 313 - 313
  • [32] Effects of high-molecular-weight polyvinyl chloride on Xenopus laevis adults and embryos: the mRNA expression profiles of Myf5, Esr1, Bmp4, Pax6, and Hsp70 genes during early embryonic development
    Pekmezekmek, Ayper Boga
    Emre, Mustafa
    Erdogan, Seyda
    Yilmaz, Bertan
    Tunc, Erdal
    Sertdemir, Yasar
    Emre, Yilmaz
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2022, 29 (10) : 14767 - 14779
  • [33] Effects of high-molecular-weight polyvinyl chloride on Xenopus laevis adults and embryos: the mRNA expression profiles of Myf5, Esr1, Bmp4, Pax6, and Hsp70 genes during early embryonic development
    Ayper Boga Pekmezekmek
    Mustafa Emre
    Seyda Erdogan
    Bertan Yilmaz
    Erdal Tunc
    Yasar Sertdemir
    Yılmaz Emre
    Environmental Science and Pollution Research, 2022, 29 : 14767 - 14779
  • [34] Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease
    Bekker, Pirow
    Hamilton, Gordon
    Johnson, Dan
    Keshav, Satish
    Schall, Thomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S409 - S409
  • [35] Traficet-EN, an Oral CCR9-Specific Antagonist, induces high levels of remission in the open-label Phase of PROTECT-1 in Crohn's Disease
    Bekker, P.
    Johnson, D.
    Hamilton, G.
    Keshav, S.
    Schall, T.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S24 - S24
  • [36] CCX 282-b, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of protect-1 clinical trial in crohn's disease
    Hetzel, D. J.
    Gibson, P. R.
    Radford-Smith, G.
    Macrae, F.
    Bekker, P.
    Schall, T. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A190 - A190
  • [37] High levels of viral replication contrast with only transient changes in CD4+ and CD8+ cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx
    Onanga, R
    Kornfeld, C
    Pandrea, I
    Estaquier, J
    Souquière, S
    Rouquet, P
    Mavoungou, VP
    Bourry, O
    M'Boup, S
    Barré-Sinoussi, F
    Simon, F
    Apetrei, C
    Roques, P
    Müller-Trutwin, MC
    JOURNAL OF VIROLOGY, 2002, 76 (20) : 10256 - 10263
  • [38] Safety and early efficacy results of a phase Ib study of nivolumab plus trastuzumab with S-1/capecitabine plus oxaliplatin for HER2-positive advanced gastric cancer (Ni-HIGH study)
    Takahari, Daisuke
    Shoji, Hirokazu
    Minashi, Keiko
    Hara, Hiroki
    Chin, Keisho
    Oki, Akira
    Ogura, Mariko
    Nakayama, Izuma
    Kato, Ken
    Iwasa, Satoru
    Hirano, Hidekazu
    Amanuma, Yusuke
    Ishizuka, Naoki
    Boku, Narikazu
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [39] High Normal Serum Levels of C3 and C1 Inhibitor, Two Acute-Phase Proteins Belonging to the Complement System, Occur More Frequently in Patients with Crohn's Disease Than Ulcerative Colitis
    László Bene
    George Füst
    Béla Fekete
    Ágota Kovács
    Laura Horváth
    Zoltán Prohászka
    Kata Miklós
    Gábor Pálos
    Mohamed Daha
    Henriette Farkas
    Lilian Varga
    Digestive Diseases and Sciences, 2003, 48 : 1186 - 1192
  • [40] High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis
    Bene, L
    Füst, G
    Fekete, B
    Kovács, A
    Horváth, L
    Prohászka, Z
    Miklós, K
    Pálos, G
    Daha, M
    Farkas, H
    Varga, L
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (06) : 1186 - 1192